{"query": "Sun Pharmaceutical faces over ₹76 cr in penalties from customs for product misclassification", "similar": [{"title": "Sun Pharma’s Latest Updates on Revenue Guidance Post Import Ban: Details", "date": "2022-12-09 05:30:00.000", "impact": "-4.73%"}, {"title": "Sun Pharma receives USFDA directive for corrective action at Mohali plant", "date": "2023-04-23 16:09:22.000", "impact": "-1.00%"}, {"title": "Krensavage AMC opposes Sun Pharma’s bid to delist Taro shares", "date": "2023-07-19 21:40:41.000", "impact": "+2.18%"}]}
{"query": "Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories", "similar": [{"title": "Sun Pharma: Sustained Traction In Speciality To Be A Re-rating Driver", "date": "2021-01-31 01:22:13.000", "impact": "+1.58%"}, {"title": "Sun Pharma’s Halol plant gets USFDA import alert", "date": "2022-12-08 17:09:02.000", "impact": "-4.73%"}, {"title": "Framework to assess, nudge generic drug makers to expand access to products", "date": "2023-02-15 19:31:51.000", "impact": "-2.36%"}]}
